Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$15.07 - $22.34 $30,140 - $44,680
-2,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$22.47 - $32.33 $44,940 - $64,660
2,000 New
2,000 $45,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Peconic Partners LLC Portfolio

Follow Peconic Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peconic Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peconic Partners LLC with notifications on news.